Skip to content

Author

G. Thanarajasingam

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.

With more potent and novel treatment options, the number of survivors of haematological malignancies is increasing steadily, which in turn leads to the need for parallel improvements in survivorship monitoring and care. The present paper forms part of The Lancet Haematology Series on adverse event reporting, dedicated...

T. Wästerlid, B. Valcárcel, Diana Presno et al. · 2 citations
Review Sep 2026

Beyond maximum grade: key regulatory considerations in adverse event reporting.

Key challenges and opportunities related to measuring cumulative and long-term toxicity burden, incorporating patient-reported outcomes, improving adverse event reporting quality and efficiency in clinical trials, and leveraging real-world data, registries, and emerging technologies, such as artificial intelligence and...

Kyriaki Tzogani, T. El-Galaly, N. Everest et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.